Effectiveness and safety of treat-to-target strategy for methotrexate-naïve rheumatoid arthritis patients >75 years of age.
Takumi MatsumotoTakahiko SugiharaTadashi HosoyaTatsuro IshizakiKanae KuboMari KamiyaHiroyuki BabaMarina TsuchidaFumio HiranoMasayo KojimaNobuyuki MiyasakaMasayoshi HarigaiPublished in: Rheumatology advances in practice (2024)
It was more difficult to achieve remission in the LORA ≥75 patients than in the LORA <75 patients due to both poor treatment response and safety issues.